US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ブラジル
BOV
Rio Paranapanema Energia S.A. (GEPA3) 銘柄情報

Rio Paranapanema Energia S.A. (GEPA3)

32.90

1.00

(3.13%)

終了 7月11日 5:55AM

Rio Paranapanema Energia S.A. (GEPA3) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

32.90

( 3.13% )

買値

31.91

売値

35.00

出来高

500

平均取引量 (3 か月)

R$ 375

財務取引量

R$ 16,448

32.89 日の範囲 32.90

30.00 52 週間の範囲 38.10

時価総額

企業価値

4.567B

前日終値

31.90

始値

32.89

時刻

最終取引時間

VWAP

32.896

歳入

1.35B

純利益

268.48M

発行済株式数

94,433,283

浮動株比率 (%)

3.81%

機関投資家保有比率 (%)

1.19%

配当利回り

1.27 (3.53%)

PER

11.96

株価売上高倍率 (PSR)

2.6

1 株当たり利益 (EPS)

2.84

ベータ

0.4

Rio Paranapanema Energia S.A. generates and sells electricity in Brazil. It operates eight hydroelectric power plants; and two small hydroelectric plants that have an installed capacity of 2,297.8 megawatts. The company was formerly known as Duke Energy International, Geração Paranapanema S.A. and c... Rio Paranapanema Energia S.A. generates and sells electricity in Brazil. It operates eight hydroelectric power plants; and two small hydroelectric plants that have an installed capacity of 2,297.8 megawatts. The company was formerly known as Duke Energy International, Geração Paranapanema S.A. and changed its name in January 2017. The company was founded in 1999 and is based in São Paulo, Brazil. Rio Paranapanema Energia S.A. is a subsidiary of Rio Paranapanema Participações S.A. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.paranapanemaenergia.com.br

本社

São Paulo, Brazil

設立

1999

Rio Paranapanema Energia S.A. is listed in the sector of the ボベスパ (ブラジル) with ticker GEPA3. The last closing price for GER PARANAP ON was R$31.90. Over the last year, GER PARANAP ON shares have traded in a share price range of R$ 30.00 to R$ 38.10.

GER PARANAP ON currently has 94,433,283 shares in issue. The market capitalisation of GER PARANAP ON is R$3.11 billion. GER PARANAP ON has a price to earnings ratio (PE ratio) of 11.96.

GER PARANAP (GEPA) - Relatorio de Agente Fiduciario - 29/04/22

GER PARANAP (GEPA) - Relatorio de Agente Fiduciario - 29/04/22 https://www.rad.cvm.gov.br/ENET/frmExibirArquivoIPEExterno.aspx?ID=974751&flnk...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.1	-3.23529411765	34	34	31.9	325	32.6	CS
4	-2.6	-7.32394366197	35.5	35.5	31.9	486	33.31382353	CS
12	-2.35	-6.66666666667	35.25	38.1	31.9	326	34.60741935	CS
26	0.4	1.23076923077	32.5	38.1	31.9	425	33.97449198	CS
52	-0.44	-1.31973605279	33.34	38.1	30	458	34.13825328	CS
156	5.9	21.8518518519	27	38.1	23.5	398	30.77895204	CS
260	-4.75	-12.6162018592	37.65	38.5	21.63	454	28.57259171	CS

GEPA3 - Frequently Asked Questions (FAQ)

What is the current Rio Paranapanema Energia S.A. share price?

The current share price of Rio Paranapanema Energia S.A. is R$ 32.90

How many Rio Paranapanema Energia S.A. shares are in issue?

Rio Paranapanema Energia S.A. has 94,433,283 shares in issue

What is the market cap of Rio Paranapanema Energia S.A.?

The market capitalisation of Rio Paranapanema Energia S.A. is BRL 3.11B

What is the 1 year trading range for Rio Paranapanema Energia S.A. share price?

Rio Paranapanema Energia S.A. has traded in the range of R$ 30.00 to R$ 38.10 during the past year

What is the PE ratio of Rio Paranapanema Energia S.A.?

The price to earnings ratio of Rio Paranapanema Energia S.A. is 11.96

What is the cash to sales ratio of Rio Paranapanema Energia S.A.?

The cash to sales ratio of Rio Paranapanema Energia S.A. is 2.6

What is the registered address of Rio Paranapanema Energia S.A.?

The registered address for Rio Paranapanema Energia S.A. is Rua Funchal No.418, São Paulo, São Paulo, 04551-060

What is the Rio Paranapanema Energia S.A. website address?

The website address for Rio Paranapanema Energia S.A. is www.paranapanemaenergia.com.br

CryptoRain

CryptoRain 5分前

Keep going…the only bad thing is you’re going to make undeserved rewards here and look amazingly bad in the process

Golden Cross

Golden Cross 12分前

$HIRU AMEEREX CORPORATION ENGAGES PCAOB-REGISTERED AUDITOR VM CPA FIRM TO AUDIT 2024 AND 2025 FINANCIAL STATEMENTS
https://www.otcmarkets.com/stock/HIRU/news/AMEEREX-CORPORATION-ENGAGES-------PCAOB-REGISTERED-AUDITOR-VM-CPA-FIRM-TO-AUDIT-2024-AND-2025-FINANCIAL-------STATEMENTS?id=527509

Doc logic

Doc logic 12分前

Nemesis18,

No, what it smacks of is validation of the exceptions pathway to adequate and well controlled studies which is something mentioned on this board back in 2016. This is near the final prep for filing a BLA with FDA and other regulators after MHRA approval. This also buys ti

Golden Cross

Golden Cross 17分前

You are correct rheddle...

berigud

berigud 18分前

Damn, no need for a super expensive, special build, testing machine when a light bulb and cardboard box shows it all.

We have been had.

FormalMHRAconsultant

FormalMHRAconsultant 22分前

So no, I am certain there was a formal rejection=So no, I am certain there was NOT a formal rejection

JRyan

Same Formation Different Rock: The Megiddo-Jezreel Deliverability Question

https://i.postimg.cc/P5kxbr1W/rig-header-clean.jpg
(Illustrative image — AI-generated. Not a photograph of the JB-1 rig or the MJ-02 site.)

What the Meged field tells us — and doesn't — ab

stock king 1

stock king 1 27分前

Look what he did with hemp and Gtvh he will do the same with Vxit .. he will run it to over 20 billion shares …. You will be left with a bag of chit

arachnodude

arachnodude 29分前

Crazy how every discussion eventually drifts away from KBLB's progress and toward confidently assigning motives, intentions, and personality traits to the CEO. One might almost forget the investment thesis is supposed to be recombinant spider silk and not speculative psychoanalysis of the company's

stock king 1

stock king 1 29分前

You buy this scam you will get screwed big time

Seminole Red

Seminole Red 30分前

round 3 will resume at 8:10....EST

Monksdream

Monksdream 30分前

NVDA, still rebounding off the 200 sma
https://investorshub.advfn.com/uimage/uploads/2026/7/11/rjkutIMG_2278.png

erg61

According to Northwest Biotherapeutics’ public statements and filings, the company has not said that it would never apply to the FDA, nor has it stated that it chose not to pursue U.S. approval permanently. Rather, management’s stated position has been that they decided to prioritize the UK and othe

Frank69OH

Frank69OH 33分前

Financials should be able to give some insight.

Curt D

Curt D 39分前

Yep. $150 support is no more.

seventhcircle

seventhcircle 40分前

$TKOI nice dip Friday looks like it got soaked up

Monksdream

Monksdream 40分前

IVES, trending sideways
https://investorshub.advfn.com/uimage/uploads/2026/7/11/crnsmIMG_2276.png

seventhcircle

seventhcircle 42分前

$NICH holding 001 support https://x.com/nitchescorp/status/2075197041609789881?s=46

moczowy

moczowy 43分前

Check out @GuruChartist message on Stocktwits http://stocktwits.com/George/message/658776713

toohot

toohot 47分前

Pallet of 1,200 PAINKILLER™ ActiPatch® Pulsed Short Wave Therapy (PSWT) devices. Maximum wholesale tier with the deepest per-unit discount, 10% lower than the case pack rate. FDA-cleared, 30-day battery, waterproof.
Shipping information
We process and deliver orders Monday-Friday (excl

toohot

toohot 48分前

Unfortunately, for him, he was booted off not only the BIEL board but for all iHub for attempting to create multiple identities.

BUY $BIEL$

PennyMillions852

PennyMillions852 1時間前

$CBDW complete filth at .0002👎👎

jimr1717

jimr1717 1時間前

“ We found that international deals announced over the last year – a key source of the company’s perceived legitimacy – never got off the ground or have quietly collapsed behind the scenes.
For example, a partnership announced more than a year ago to bring HUMBL to Africa never got beyond the

PennyMillions852

PennyMillions852 1時間前

Is this 💩💩 going anywhere ever??

PennyMillions852

PennyMillions852 1時間前

lol, NEWS and still no pps movement! Still sub .002 and your waiting on FINRA for a name change be prepared for a long wait as they don’t get in a hurry for anybody. $IGPK been waiting over a year now!

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。